Yatharth Hospital & Trauma Care Services Limited – Investor Presentation Summary

Key Operational Highlights

  • Total operational beds stood at 2,555, excluding the recently acquired under-construction Gurugram hospital (250 beds).
  • Occupancy for newly opened hospitals computed on actual days of operations.
  • Newer hospitals (Greater Faridabad, Faridabad Sector-20, New Delhi, and Agra) contributed ₹753 mn, representing 22% of Group revenues in Q4 FY26.
  • Existing hospitals sustained robust performance, delivering 29% YoY revenue growth.
  • Key drivers include operating leverage, business mix improvement, and positive impact of price revisions in government business.

Segment-wise Performance

  • Noida Extension recorded highest-ever ARPOB at ₹47.8k, up 23% YoY.
  • Greater Noida ARPOB at ₹40.3k, up 15% YoY.
  • New Delhi hospital ARPOB ~₹40k.
  • Faridabad Sector-20 hospital ARPOB ~₹38k.
  • Significant changes driven by high-value mix and rapid scale-up of newer hospitals.

Financial Highlights

Q4 FY26 Performance:

  • Revenue from Operations: ₹3,416 mn (YoY growth: 47%; QoQ growth: 6%)
  • EBITDA: ₹799 mn (YoY growth: 37%; QoQ growth: 6%)
  • EBITDA Margin: 23.4% (YoY: -161 bps; QoQ: +1 bps)
  • PAT: ₹447 mn (YoY growth: 15%; QoQ growth: 4%)
  • PAT Margin: 13.1% (YoY: -353 bps; QoQ: -32 bps)

FY26 Annual Performance:

  • Revenue from Operations: ₹12,072 mn (YoY growth: 36%)
  • EBITDA: ₹2,921 mn (YoY growth: 30%)
  • EBITDA Margin: 24.2% (YoY: -125 bps)
  • PAT: ₹1,703 mn (YoY growth: 30%)
  • PAT Margin: 14.1% (YoY: -63 bps)

Drivers of Financial Performance:

  • Higher revenue growth driven by new hospital additions and strong performance of existing hospitals
  • Operating leverage benefits
  • Business mix improvement
  • Positive impact of price revisions in government business

Adjusted Metrics:

  • Group Adjusted EBITDA Margin (excluding New Delhi, Faridabad Sec-20 and Agra): 30.4% for Q4, 28.5% for FY26

Geographical Revenue Split

  • Domestic vs Export/Regional Revenue: Not Specified
  • Regional Breakdown: Not Specified

Balance Sheet Snapshot

As of March 2026:

  • Equity Share Capital: ₹964 mn
  • Reserves and Surplus: ₹16,842 mn
  • Borrowings: ₹2,533 mn
  • Trade Payables: ₹1,100 mn
  • Fixed Assets (Incl. Goodwill): ₹13,517 mn
  • Trade Receivables: ₹3,748 mn
  • Cash & Bank Balances: ₹2,634 mn
  • Total Assets: ₹22,815 mn

Financial Health Insights:

  • Strong reserve growth from ₹15,091 mn to ₹16,842 mn YoY
  • Increased borrowing position from ₹41 mn to ₹2,533 mn YoY
  • Significant growth in fixed assets from ₹8,272 mn to ₹13,517 mn YoY

Capex & Cash Flow Health

  • Capital Expenditure: Proposed outlay of ₹200 crore for Gurugram hospital acquisition
  • Pre-tax Operating Cash Flows: Disclosed but not quantified
  • Investment Rationale: Focus on capacity expansion in high-opportunity premium catchments

Strategic & R&D Initiatives

Expansion Projects:

  • Acquired 250-bedded under-construction hospital in Gurugram with ARPOB potential ~₹50k+
  • Acquired 100% stake in well-established 250-bed multi-speciality hospital in Agra for ₹260 Cr
  • Bed capacity expansion plan of ~3,250 beds; target ~5,000 bed capacity over next 3 years

Strategic Partnerships:

  • Exclusive hospital partner to Noida International Airport
  • Exclusive Clinical Partner to Noida International Airport

Expected Impact:

  • Proximity to IGI airport and Jewar Airport to spur Medical Value Travel opportunities
  • Gurugram facility to cater to growing healthcare needs of domestic & international patients
  • Agra hospital serves as feeder hub to Group's hospitals for Oncology and Organ Transplants

Industry Trends & Business Environment

  • Market growth in North India healthcare sector
  • Increasing medical value travel opportunities
  • Underpenetrated quality medical infrastructure in catchment areas

Management Commentary & Growth Outlook

  • Cluster-based growth strategy to build density across clusters for brand recall and market leadership
  • Target of ~5,000 bed capacity over next 3 years
  • Focus on medical value travel through airport partnerships
  • Enhanced specialty mix across existing hospitals alongside rapid scale-up of newer hospitals to elevate Group's ARPOB

Awards & Recognition

  • Mr. Amit Singh awarded Hospital CEO Excellence in Stroke Care Implementation
  • Yatharth Hospitals awarded Stroke Centre of Excellence – North
  • Dr. Indu Kulshreshtha awarded "Honoring Excellence" from Emcure Cure and Beyond
  • Dr. Viresh Mahajan awarded "Paediatric Cardiologist of the Year"
  • Dr. Dhanshuk Kumawat awarded "Desh Ratan Award 2025"
  • Dr. Kunal Bahrani honored with Leadership in Neurology Services award
  • Dr. Supradip Ghosh received "Chairman Award" for lifetime contribution